Comprehensive Hereditary Cancer Panel

Catalog information reviewed: August 24, 2026 by the Sunridge Medical clinical team.

What this laboratory test evaluates

DetailsThe Comprehensive Hereditary Cancer Panel tests for 66 genes linked to a wide range of hereditary cancers. This includes cancers that may affect the breast, colon, endometrium, stomach, urinary tract, ovary, pancreas, prostate, rectum, neuroendocrine system, thyroid, adrenal glands, paraganglia, and other tissues. If the test finds a pathogenic or likely pathogenic variant, it means there's an increased risk of developing certain cancers compared to the general population.

Who should consider this test?This test is particularly important for individuals with a family history of cancer, as it can help identify inherited cancer risks. Knowing your genetic risk can guide future monitoring and prevention strategies.

What type of sample is required for this test?5 mL of whole blood collected in an EDTA (lavender-top) or ACD (yellow-top) tube. A simple blood draw is needed.

Test Resources http://education.questdiagnostics.com/faq/FAQ217

Additional test information

This test is particularly important for individuals with a family history of cancer, as it can help identify inherited cancer risks.

Collection and processing

• Sample type: Whole blood
• Fasting: No
• Estimated laboratory processing: Results should be available in 2 – 5 business days after the sample is collected

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.